Alembic Pharmaceuticals reports 11.70% rise in Q2 consolidated net profit

19 Oct 2012 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2012.

On standalone basis, the company has posted a rise of 9.13% in its net profit at Rs 41.47 crore for the quarter ended September 30, 2012 as compared to Rs 38.00 crore for the same quarter in the previous year. Total income has increased by 5.64% at Rs 406.85 crore for quarter under review as compared to Rs 385.12 crore for the quarter ended September 30, 2011.

On consolidated basis, the company has posted a rise  of 11.70% in its net profit at Rs 42.49 crore for the quarter ended September 30, 2012 as compared to Rs 38.04 crore for the same quarter in the previous year.  Total income has increased by 2.23% at Rs 406.85 crore for quarter under review as compared to Rs 397.99 crore for the quarter ended September 30, 2011.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

850.00 5.90 (0.70%)
08-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1688.75
Dr. Reddys Lab 1108.55
Cipla 1433.45
Lupin 1982.65
Zydus Lifesciences 859.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...